Unknown

Dataset Information

Complementary Presence of HBV Humoral and T-cell Response Provides Protective Immunity after Neonatal Immunization.


ABSTRACT:

Background and aims

Hepatitis B vaccination is the most cost effective way to prevent hepatitis B virus (HBV) infection. Hepatitis B vaccine (HepB) efficacy is usually assessed by anti-hepatitis B surface antigen (HBsAg) level, but there are few reports of humoral and cellular immune responses to HepB in children after neonatal vaccination.

Methods

A group of 100 children with a history of primary hepatitis B immunization were included in this study to evaluate the efficacy of HepB. Blood samples were obtained from 80 children before, and 41 children after, a single HepB booster dose. Children with low anti-HBsAg (HBs) titers of <100 mIU/mL received a booster dose after giving their informed consent. Anti-HBsAg, T-cell response and percentage of B-cell subsets were assayed b

SUBMITTER: Huang Y 

PROVIDER: S-EPMC9396322 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature